New Drug Combo Shows Promise in Slowing Aggressive Prostate Cancer with Genetic Mutations
A new targeted drug combination has shown significant promise in delaying the progression of advanced prostate cancer among men with specific genetic mutations linked to faulty DNA repair, according to…